Anxiety Drug For Dogs Nears FDA Approval

Eli Lilly & Co.’s Reconcile is nearing approval from the USDA.

Landmarks across the country, like the Empire State Building, will light up in orange in support of ASPCA Day on April 10.

The U.S. Food & Drug Administration will soon announce its approval of Eli Lilly & Co.'s Reconcile (fluoxetine hydrochloride), perhaps as soon as Monday.

The tablets are for use in dogs and puppies 6 months of age and older and 8.8 pounds or heavier, according to FDA-established guidelines. 

The flavored, chewable drug will be approved "for the treatment of canine separation anxiety in conjunction with a behavior modification plan."

The drug, based on the active ingredient in Prozac, is not for use in people.

Behavior modification uses could include counseling, such as rewards for good behavior, and training for a dog to be content alone, according to the drug’s prescribing information.

Reconcile will not be the first anxiety medication for dogs on the market. Clomicalm was approved by the FDA in 1999. Reconcile will, however, be Lily's first drug approved  for its new companion animal business.

Reconcile is expected to be available within the next several weeks.

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.